CAS 1365803-52-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
N-{2-[4-(but-2-yn-1-yloxy)benzenesulfonyl]-1-[4-(methanesulfonamidomethyl)phenyl]ethyl}-N-hydroxyformamide
CAS :Formule :C21H24N2O7S2Degré de pureté :≥98%Masse moléculaire :480.5545KP-457
CAS :KP-457 is a ADAM17 and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).Formule :C21H24N2O7S2Degré de pureté :98.33%Couleur et forme :SolidMasse moléculaire :480.56N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide
CAS :Produit contrôléFormule :C21H24N2O7S2Couleur et forme :NeatMasse moléculaire :480.555N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide
CAS :N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide is a synthetic, nonsteroidal drug product. It is metabolized by CYP3A4 and CYP2D6 to the active form. The N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesulfonamide drug product has an analytical impurity of 4-[3-[(E)-[(E)-N′,N′′′-(dimethylamino)methylidene]-5′-(2′,5′-dioxoimidazolidinium)]bis[(Z)-formylhydrazono]]benzFormule :C21H24N2O7S2Degré de pureté :Min. 95%Masse moléculaire :480.6 g/mol
![N-{2-[4-(but-2-yn-1-yloxy)benzenesulfonyl]-1-[4-(methanesulfonamidomethyl)phenyl]ethyl}-N-hydroxyf…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA01EIP1.jpg&w=3840&q=75)
![N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesu…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb%2FB809708.jpg&w=3840&q=75)
![N-[[4-[2-[[4-(2-Butyn-1-yloxy)phenyl]sulfonyl]-1-(formylhydroxyamino)ethyl]phenyl]methyl]methanesu…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FQEC80352.jpg&w=3840&q=75)
